98%
921
2 minutes
20
The objective of this study was to determine whether there are any differences in the T cell composition and the expression of specific factors (i.e., IRF4, TBX21, GATA3, and GITR) of T cells between women with Repeated Implantation Failure (RIF) and fertile women. We observed a decrease in circulating Tregs and exhausted CD8 + T cells in RIF patients when compared to the controls whereas exhausted Treg and Th17 cells were more frequent. Using real-time PCR, we determined that the expression of IRF-4 and TBX21 was significantly elevated in the cases. In contrast, mRNAs encoding GATA3 and GITR were reduced. Furthermore, the expression of some miRNAs involved in T cell differentiation and their target gene candidates were examined in T cells from women with RIF and fertile control women. The patients showed significant up-regulation of miR-25, miR-93, and miR-326. miR-155 and miR-146a demonstrated significant down-regulation in RIF patients. The results revealed that the expression pattern of target genes was in line with data for miRNAs expression from purified Treg and Th17 cells. The findings of real-time PCR analysis provided insights into the genetic pathways underlying this aberration in the proportions of T cell subsets. Our data suggest that a combination of higher pro-inflammatory Th17 and exhausted Treg cells, and lower Treg and exhausted CD8 + T cells may co-exist in the peripheral blood of women with RIF. Moreover, the expression level of transcription factors and miRNAs controlling T cell differentiation may differ in women with RIF influencing pregnancy outcomes in these women.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.jri.2018.11.002 | DOI Listing |
Mol Genet Genomic Med
September 2025
Cytogenetic Laboratories, Shahid Beheshti Hospital, Hamadan University of Medical Sciences, Hamadan, Iran.
Background: Recurrent Implantation Failure (RIF) is defined as the inability to establish pregnancy despite high-quality embryo transfer after the application of at least three consecutive in vitro fertilization (IVF)/intracytoplasmic sperm injection-embryo transfer procedures. Chromosomal abnormalities are one of the primary reasons for pregnancy failure, miscarriage, and birth defects in both natural conception and IVF pregnancies. This study was to evaluate the incidence of chromosomal abnormalities in peripheral blood samples from 100 couples who experienced RIF.
View Article and Find Full Text PDFInfect Disord Drug Targets
August 2025
Department of Anatomy, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Introduction: The present study examined the effect of different concentrations of platelet- rich plasma (PRP) on cell growth and proliferation, and the expression levels of MUC-1 and MUC-4 genes in repeated implantation failure (RIF) patients.
Methods: Twenty-eight women were included in the study. The control group and the group of patients with RIF were treated with different concentrations of PRP 3%, 5% and 10%.
Front Endocrinol (Lausanne)
August 2025
Department of Nursing, The Second Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, China.
Introduction: Recurrent implantation failure (RIF) is a major challenge in reproductive medicine, and emerging evidence suggests that alterations in the endometrial microbiota may play a critical role in its pathogenesis. To identify the main differential endometrial microbiota associated with RIF and to establish threshold values for their relative abundance.
Methods: This case-control study was conducted in the Departments of Obstetrics, Gynecology, and Reproductive Medicine at two large hospitals.
Signal Transduct Target Ther
August 2025
Department of Hematology/Oncology, Shanghai Children's Medical Center, School of Medicine, Shanghai Jiao Tong University, National Health Committee Key Laboratory of Pediatric Hematology & Oncology, Shanghai, China.
The Realgar-Indigo Naturalis formula (RIF) is a proprietary Chinese medicine, which is one of the important drugs in the treatment of pediatric acute promyelocytic leukemia (APL). However, the dose of RIF in clinical application is not uniform and the long-term effectiveness and safety of combining RIF with all-trans retinoic acid (ATRA) in a larger population of pediatric APL patients remains undocumented. We conducted a multicenter single-arm clinical trial (ChiCTR-OIC-16010014) in China.
View Article and Find Full Text PDFCureus
August 2025
Department of Obstetrics and Gynaecology, Reproductive Medicine, Cambridge University Hospitals, Cambridge, GBR.
Women with Crohn's disease (CD) are often affected during their reproductive years. Live birth rates following assisted reproductive technology (ART) in medically managed CD are comparable to those in the general population. However, ART outcomes decline significantly after CD-related surgery, a pattern not observed in ulcerative colitis (UC).
View Article and Find Full Text PDF